Home/Filings/4/0000899243-22-027169
4//SEC Filing

ElevateBio, LLC 4

Accession 0000899243-22-027169

CIK 0001754068other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 4:35 PM ET

Size

6.1 KB

Accession

0000899243-22-027169

Insider Transaction Report

Form 4
Period: 2022-07-28
Transactions
  • Award

    Common Stock

    2022-07-28$4.61/sh+3,253,796$15,000,00016,674,766 total
Footnotes (2)
  • [F1]On July 28, 2022, ElevateBio LLC ("ElevateBio") acquired 3,253,796 shares of the Issuer's Common Stock in a registered direct offering at a price of $4.61 per share.
  • [F2]These shares are directly held by ElevateBio. David Hallal, Vikas Sinha, Morana Jovan-Embiricos and Ansbert Gadicke are directors of ElevateBio, and may be deemed to have shared voting and investment power of the shares held by ElevateBio. Such persons disclaim beneficial ownership of all shares held by ElevateBio except to the extent of their pecuniary interest therein, if any.

Issuer

Allovir, Inc.

CIK 0001754068

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001818060

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:35 PM ET
Size
6.1 KB